...by the Cancer Research UK group based on a patent application filed by the company. Epi Pharmaceuticals Inc....

...At least four biotech companies have LSD1 inhibitor programs. In addition to Oryzon and Salarius, Epi Pharmaceuticals Inc....
...and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Cancer Research UK , London, U.K. Epi Pharmaceuticals Inc....

...Tranylcypromine is a generic monoamine oxidase inhibitor (MAOI) marketed to treat depression. Oryzon Genomics and Epi Pharmaceuticals Inc....